This cross sectional study was conducted in 2018 in Côte d'Ivoire to assess PrEP
acceptability among men who have sex with men (MSM). Two hundred and one men were …

Background: HIV remains an important public health issue throughout the world. In Côte
d'Ivoire, a high burden of HIV is observed in men who have sex with men (MSM). Objective …

We investigated the rate and predictors of ineffective HIV protection in men who have sex
with men (MSM) taking pre-exposure prophylaxis (PrEP) in a prospective cohort study from …

In Benin, consistent condom use among men who have sex with men (MSM) is relatively low
and providing them with Pre-exposure prophylaxis (PrEP) could be of great relevance. We …

Abstract The Middle East and North Africa (MENA) is one of only two global regions where
rates of HIV are currently on the rise. In Lebanon, new HIV infections are increasing most …

Background HIV pre-exposure prophylaxis (PrEP) data in men who have sex with men
(MSM) in west Africa are essential to guide its large-scale implementation. We assessed the …

Objective To explore the interest in taking Pr EP among Western African men who have sex
with men (MSM). Methods A cross‐sectional survey was implemented at enrolment of HIV …

Abstract Introduction South African men face a substantial burden of HIV and are less likely
to test for HIV and initiate antiretroviral therapy if tested positive and more likely to die from …

Introduction Pre-exposure Prophylaxis (PrEP) is a daily pill aimed at reducing HIV
transmission risk when taken as prescribed. It's highly recommended for high-risk Men who …

In Ghana, men who have sex with men (MSM) are disproportionately affected by HIV. Pre-
exposure prophylaxis (PrEP) is a biomedical intervention that reduces the risk of HIV …